Cargando…

Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

This study was undertaken to determine the prevalence of anti-cardiolipin antibodies (ACLAs) in patients with malignancy and to investigate a possible association of ACLAs with thromboembolic events in such patients. The study included 216 patients with solid and non-solid malignancies and an age-ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuckerman, E., Toubi, E., Golan, T. D., Rosenvald-Zuckerman, T., Sabo, E., Shmuel, Z., Yeshurun, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034001/
https://www.ncbi.nlm.nih.gov/pubmed/7640230